City

Houston (3)

Jacksonville (1)

Rochester (1)

Scottsdale (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Completed (1)

Phase

phase 2 (2)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (3)

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (3)

Study Documents

Intervention Type

biological (4)

drug (4)

other (1)

Funder Type

Other (4)

Study Type

Interventional (4)

ann arbor stage iv marginal zone lymphoma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular

Recruiting

Aggressive B-Cell Non-Hodgkin Lymphoma
+19 more

CD47 Antagonist ALX148
+2 more

Houston, Texas

M D Anderson Cancer Center

Aug 9, 2022

Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

Recruiting

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
+13 more

Cyclophosphamide
+6 more

Scottsdale, Arizona
+2 more

Jun 1, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting

Ann Arbor Stage II Follicular Lymphoma
+9 more

Ibrutinib
+3 more

Houston, Texas

M D Anderson Cancer Center

Feb 3, 2022

Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Indolent

Completed

Has Results

Ann Arbor Stage III Grade 1 Follicular Lymphoma
+9 more

Lenalidomide
Rituximab

Houston, Texas

M D Anderson Cancer Center

Sep 28, 2021